SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-020268
Filing Date
2022-04-18
Accepted
2022-04-18 08:32:29
Documents
13
Period of Report
2022-04-18
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea158506-8k_bimi.htm   iXBRL 8-K 24736
2 PRESS RELEASE DATED APRIL 18, 2022 ea158506ex991_bimi.htm EX-99.1 213554
  Complete submission text file 0001213900-22-020268.txt   427924

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE bimi-20220418.xsd EX-101.SCH 3027
4 XBRL LABEL FILE bimi-20220418_lab.xml EX-101.LAB 34476
5 XBRL PRESENTATION FILE bimi-20220418_pre.xml EX-101.PRE 22591
7 EXTRACTED XBRL INSTANCE DOCUMENT ea158506-8k_bimi_htm.xml XML 3746
Mailing Address NO. 10, HUASHENG ROAD, FLOOR 21 YUZHONG DISTRICT CHONGQING, P.R. F4 404100
Business Address NO. 10, HUASHENG ROAD, FLOOR 21 YUZHONG DISTRICT CHONGQING, P.R. F4 404100 (8604) 1182209211
BIMI International Medical Inc. (Filer) CIK: 0001213660 (see all company filings)

IRS No.: 020563302 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34890 | Film No.: 22831081
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries